Heterocyclic inhibitors of PTPN11

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11840536
APP PUB NO 20230109858A1
SERIAL NO

17876958

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their application as pharmaceuticals for the treatment of disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM201 WEST 7TH STREET AUSTIN TX 78701

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cross, Jason Pearland, US 20 113
Czako, Barbara Bellaire, US 21 205
Jones, Philip Houston, US 185 1433
Leonard, Paul Houston, US 22 795
Mseeh, Faika Shenandoah, US 4 52
Parker, Connor Houston, US 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jun 12, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 12, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 12, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00